Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Second Sight (EYES)

0.85   0.01 (1.18%) 10-23 23:42
Open: 0.846 Pre. Close: 0.8401
High: 0.85 Low: 0.8302
Volume: 100,238 Market Cap: 20M
Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. The company is headquartered in Sylmar, California and currently employs 123 full-time employees. The firm intends to develop Orion Visual Cortical Prosthesis which provides useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease or forms of cancer and trauma. Its product, The Argus II Retinal Prosthesis System (The Argus II) provides electrical stimulation of the retina to induce visual perception in blind individuals and helps in treating outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. The firm's Argus II System employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.851 - 0.854 0.854 - 0.858
Low: 0.821 - 0.825 0.825 - 0.829
Close: 0.843 - 0.849 0.849 - 0.856

Technical analysis

as of: 2020-10-23 4:43:31 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.03     One year: 1.10
Support: Support1: 0.78    Support2: 0.65
Resistance: Resistance1: 0.88    Resistance2: 0.94
Pivot: 0.88
Moving Average: MA(5): 0.85     MA(20): 0.88
MA(100): 0.92     MA(250): 2.82
MACD: MACD(12,26):     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 36.86     %D(3): 38.48
RSI: RSI(14): 46.44
52-week: High: 7.60  Low: 0.69  Change(%): -87.0
Average Vol(K): 3-Month: 37795  10-Days: 12287

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
EYES has closed above bottom band by 20.0%. Bollinger Bands are 60.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to EYES's normal range. The bands have been in this narrow range for 110 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 23 Oct 2020
Ancient Words: His Second Coming, Abound in Sight - El Dorado News-Times

Thu, 15 Oct 2020
Brain Implant Bypasses Eyes To Help Blind People See - IEEE Spectrum

Tue, 06 Oct 2020
You Need to See this stock? Second Sight Medical Products, (EYES) - Armenian Reporter

Mon, 05 Oct 2020
SECOND SIGHT MEDICAL PRODUCTS, INC. (NASDAQ:EYES) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - Market Exclusive

Mon, 05 Oct 2020
Second Sight facing Nasdaq delisting - Mass Device

Wed, 23 Sep 2020
Second Sight Resumes Study - San Fernando Valley Business Journal

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 23
Shares Float (M) 7
% Held by Insiders 43.05
% Held by Institutions 22.66
Shares Short (K) 424
Shares Short P. Month (K) 516

Stock Financials

EPS -1.634
EPS Est This Year -0.550
EPS Est Next Year -0.520
Book Value (p.s.) 0.090
Profit Margin
Operating Margin -2629.10
Return on Assets (ttm) -87.7
Return on Equity (ttm) -235.7
Qtrly Rev. Growth
Gross Profit (p.s.) 0.053
Sales Per Share 0.042
EBITDA (p.s.) -1.088
Qtrly Earnings Growth
Operating Cash Flow (M) -28
Levered Free Cash Flow (M) -18

Stock Valuations

PE Ratio -0.52
PEG Ratio
Price to Book value 9.44
Price to Sales 20.28
Price to Cash Flow -0.71

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.